Cargando…

Erratum: Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1

Detalles Bibliográficos
Autores principales:	Perfetti, A., Greco, S., Cardani, R., Fossati, B., Cuomo, G., Valaperta, R., Ambrogi, F., Cortese, A., Botta, A., Mignarri, A., Santoro, M., Gaetano, C., Costa, E., Dotti, M. T., Silvestri, G., Massa, R., Meola, G., Martelli, F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320479/ https://www.ncbi.nlm.nih.gov/pubmed/28225046 http://dx.doi.org/10.1038/srep43074

Ejemplares similares

Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1
por: Perfetti, A., et al.
Publicado: (2016)

Tibialis Anterior Muscle Needle Biopsy and Sensitive Biomolecular Methods: A Useful Tool in Myotonic Dystrophy Type 1
por: Iachettini, S., et al.
Publicado: (2015)

Deregulated MicroRNAs in Myotonic Dystrophy Type 2
por: Greco, Simona, et al.
Publicado: (2012)

Dysregulation of Circular RNAs in Myotonic Dystrophy Type 1
por: Voellenkle, Christine, et al.
Publicado: (2019)

SCN4A as modifier gene in patients with myotonic dystrophy type 2
por: Binda, Anna, et al.
Publicado: (2018)

Overexpression of CUGBP1 in Skeletal Muscle from Adult Classic Myotonic Dystrophy Type 1 but Not from Myotonic Dystrophy Type 2
por: Cardani, Rosanna, et al.
Publicado: (2013)

Premature Senescence in Primary Muscle Cultures of Myotonic Dystrophy Type 2 is not Associated with p16 Induction
por: Renna, L.V., et al.
Publicado: (2014)

TNNT2 Missplicing in Skeletal Muscle as a Cardiac Biomarker in Myotonic Dystrophy Type 1 but Not in Myotonic Dystrophy Type 2
por: Bosè, Francesca, et al.
Publicado: (2019)

Genome Wide Identification of Aberrant Alternative Splicing Events in Myotonic Dystrophy Type 2
por: Perfetti, Alessandra, et al.
Publicado: (2014)

CRISPR/Cas9-Mediated Deletion of CTG Expansions Recovers Normal Phenotype in Myogenic Cells Derived from Myotonic Dystrophy 1 Patients
por: Provenzano, Claudia, et al.
Publicado: (2017)

Neuropsychological and Psychological Functioning Aspects in Myotonic Dystrophy Type 1 Patients in Italy
por: Callus, Edward, et al.
Publicado: (2018)

Circulating Irisin Is Reduced in Male Patients with Type 1 and Type 2 Myotonic Dystrophies
por: Dozio, Elena, et al.
Publicado: (2017)

Aberrant insulin receptor expression is associated with insulin resistance and skeletal muscle atrophy in myotonic dystrophies
por: Renna, Laura Valentina, et al.
Publicado: (2019)

Myotonic Dystrophy Type 2: An Update on Clinical Aspects, Genetic and Pathomolecular Mechanism
por: Meola, Giovanni, et al.
Publicado: (2015)

Muscleblind-like1 Undergoes Ectopic Relocation in the Nuclei of Skeletal Muscles in Myotonic Dystrophy and Sarcopenia
por: Malatesta, M., et al.
Publicado: (2013)

Ribonuclear inclusions as biomarker of myotonic dystrophy type 2, even in improperly frozen or defrozen skeletal muscle biopsies
por: Cardani, R., et al.
Publicado: (2009)

Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1
por: Alì, Marco, et al.
Publicado: (2020)

RNA/MBNL1-containing foci in myoblast nuclei from patients affected by myotonic dystrophy type 2: an immunocytochemical study
por: Perdoni, F., et al.
Publicado: (2009)

Sleep-Wake Cycle and Daytime Sleepiness in the Myotonic Dystrophies
por: Romigi, A., et al.
Publicado: (2013)

Cultured myoblasts from patients affected by myotonic dystrophy type 2 exhibit senescence-related features: ultrastructural evidence
por: Malatesta, M., et al.
Publicado: (2011)

Receptor and post-receptor abnormalities contribute to insulin resistance in myotonic dystrophy type 1 and type 2 skeletal muscle
por: Renna, Laura Valentina, et al.
Publicado: (2017)

RNA Transcription and Maturation in Skeletal Muscle Cells are Similarly Impaired in Myotonic Dystrophy and Sarcopenia: The Ultrastructural Evidence
por: Malatesta, Manuela, et al.
Publicado: (2014)

High-throughput analysis of the RNA-induced silencing complex in myotonic dystrophy type 1 patients identifies the dysregulation of miR-29c and its target ASB2
por: Cappella, Marisa, et al.
Publicado: (2018)

Myotonic dystrophy type 2: the 2020 update
por: Meola, Giovanni
Publicado: (2020)

Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies
por: MEOLA, GIOVANNI
Publicado: (2013)

Generation and Neuronal Differentiation of hiPSCs From Patients With Myotonic Dystrophy Type 2
por: Spitalieri, Paola, et al.
Publicado: (2018)

Myotonic dystrophy
por: Patterson, VH
Publicado: (1990)

Epigenetics of Myotonic Dystrophies: A Minireview
por: Visconti, Virginia Veronica, et al.
Publicado: (2021)

Editorial: Myotonic Dystrophies: Developments in Research From Bench to Bedside
por: Silvestri, Gabriella, et al.
Publicado: (2020)

Cardiac involvement in myotonic dystrophy
por: Khalighi, Koroush, et al.
Publicado: (2015)

Consensus-based care recommendations for adults with myotonic dystrophy type 2
por: Schoser, Benedikt, et al.
Publicado: (2019)

Editorial: Beyond Borders: Myotonic Dystrophies–A European Perception
por: Schoser, Benedikt, et al.
Publicado: (2018)

Myotonic Dystrophies: State of the Art of New Therapeutic Developments for the CNS
por: Gourdon, Genevieve, et al.
Publicado: (2017)

Cancer and Myotonic Dystrophy
por: D’Ambrosio, Eleonora S., et al.
Publicado: (2023)

Myotonic dystrophy type 1 in the COVID-19 era
por: Ilic Zivojinovic, Jelena, et al.
Publicado: (2023)

Brain Connectomics' Modification to Clarify Motor and Nonmotor Features of Myotonic Dystrophy Type 1
por: Serra, Laura, et al.
Publicado: (2016)

Autoimmune Diseases in Patients With Myotonic Dystrophy Type 2
por: Peric, Stojan, et al.
Publicado: (2022)

Desflurane anaesthesia in myotonic dystrophy
por: Gandhi, Ranju, et al.
Publicado: (2011)

Myotonic Dystrophy: An Anaesthetic Dilemma
por: Gupta, N, et al.
Publicado: (2009)

Steakhouse Syndrome in Myotonic Dystrophy
por: Ogasawara, Nobuhiko, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_keeciic4h3kj84k1o5fg4r4vag